MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..

Selegiline tablets

Company: Teva Pharmaceutical
Approval Status: Approved January 1997
Treatment for: Parkinson’s disease
Areas: Neurology & Nervous System

| General Information |

General Information

Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.

< back to top

Selegiline tablets Drug Information

The Selegiline Tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.